The evidence points in a positive direction: adjusting your lifestyle, and in particular treating high blood pressure and poor blood sugar control, reduces the risk of cognitive decline. The studies are, however, mainly observational or small-scale, and full recovery from existing forgetfulness is not a realistic expectation. For people with early symptoms, early detection is the most concrete and well-supported step to take.
Fully reversing early-onset forgetfulness is not realistic in most cases, but research does show that lifestyle changes can slow cognitive decline and can sometimes partially reverse it. This is most clearly the case when a reversible underlying cause is present, such as poorly controlled blood sugar or a treatable vascular condition. Without such a cause, the chance of genuine recovery is smaller, but stabilisation is achievable for many people.
The strongest evidence relates to vascular risk factors. High blood pressure more than doubles the risk of mild cognitive impairment in people with type 2 diabetes (odds ratio 2.25), and cardiovascular disease raises it even slightly more (odds ratio 2.61). Treating these conditions is therefore one of the most powerful levers the studies offer. In people with diabetes specifically, poorly controlled blood sugar (HbA1c above 9%) increases the risk of cognitive problems by a factor of 1.33, and insulin resistance nearly doubles that risk (odds ratio 1.95). Strict glucose control and blood pressure treatment are therefore the most concretely supported lifestyle and medical interventions.
Physical activity is the intervention with the broadest support in the available studies. Active muscles produce proteins such as BDNF (a growth factor for brain cells) and suppress inflammatory processes that accelerate cognitive decline. A Malaysian study of older adults with both physical and cognitive frailty examined a combined approach after 12 months, consisting of exercise, healthy nutrition, vascular care and cognitive training. Multiple cognitive and physical outcomes improved significantly, although only slightly more than half of the participants stayed in the study for the entire period. This is an initial, preliminary study and the results have not yet been widely replicated.
Quitting smoking is also relevant: smoking increases the risk of cognitive problems in people with diabetes by a factor of 1.44. Cognitive training and neuromodulation are also being investigated. Small human studies show positive effects, but the evidence is thinner than for exercise and vascular control. The brains of healthy older adults are indeed plastic enough to respond to such stimuli, but whether the effects are sustained over the long term has not yet been sufficiently demonstrated.
Mild cognitive impairment (MCI, the informal boundary between normal forgetfulness and early-stage dementia) is not an irreversible verdict. Partial return to normal functioning is possible, but depends strongly on the underlying cause. Biomarkers such as amyloid and tau in the blood or cerebrospinal fluid can help determine whether early Alzheimer's disease is involved, which makes the prognosis less favourable. Early detection, preferably by a general practitioner, increases the chance of timely intervention and reduces the risk of falls and hospital admissions. It is therefore worthwhile not to wait when symptoms persist, but to actively seek a diagnosis.
Nine claims from seven PMIDs, a mix of observational research, one RCT (39350375) and narrative reviews. Strength of evidence ranges from limited (cognitive training) to moderate (lifestyle, vascular factors) to strong (vascular risk factors and dementia risk). No large independent meta-analysis is available for the combined lifestyle question. The RCT data come largely from Asian populations, which limits generalisability to Western older adults.